PROS1 and Alzheimer disease: Our findings demonstrate AD-specific increases in ES-GluN2B expression and a significant downregulation in PSA-NCAM levels, suggesting that Aβ-induced downregulation of biosynthetic enzymes ST8Sia4 and UDP-E contributes to a reduction in PSA-NCAM.